Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

PARP inhibition in the ovarian cancer patient: Current approvals and future directions.

Kurnit KC, Avila M, Hinchcliff EM, Coleman RL, Westin SN. PARP inhibition in the ovarian cancer patient: Current approvals and future directions. Pharmacol Ther. 2020 09; 213:107588.

View in: PubMed

collapse authors with profiles